Abatacept for Severe Immune Checkpoint Inhibitor-Associated Myocarditis.

MLA

Salem, Joe-Elie, et al. “Abatacept for Severe Immune Checkpoint Inhibitor-Associated Myocarditis.” The New England Journal of Medicine, vol. 380, no. 24, June 2019, pp. 2377–79. EBSCOhost, https://doi.org/10.1056/NEJMc1901677.

APA

Salem, J.-E., Allenbach, Y., Vozy, A., Brechot, N., Johnson, D. B., Moslehi, J. J., & Kerneis, M. (2019). Abatacept for Severe Immune Checkpoint Inhibitor-Associated Myocarditis. The New England Journal of Medicine, 380(24), 2377–2379. https://doi.org/10.1056/NEJMc1901677

Chicago

Salem, Joe-Elie, Yves Allenbach, Aurore Vozy, Nicolas Brechot, Douglas B Johnson, Javid J Moslehi, and Mathieu Kerneis. 2019. “Abatacept for Severe Immune Checkpoint Inhibitor-Associated Myocarditis.” The New England Journal of Medicine 380 (24): 2377–79. doi:10.1056/NEJMc1901677.